-
21
Several factors that predict the outcome of large B‐cell lymphoma patients who relapse/progress after chimeric antigen receptor (CAR) T‐cell therapy can be identified before cell a...
Published 2024-09-01“…Cancer Medicine…”
Get full text
Article -
22
Effect of primary tumor volume on survival of concurrent chemoradiotherapy in stage IV non‐small cell lung cancer
Published 2024-09-01“…Cancer Medicine…”
Get full text
Article -
23
Which social determinants of health have the highest impact in community oncology to advance patient care equity and improve health outcomes? A scoping review
Published 2024-09-01“…Cancer Medicine…”
Get full text
Article -
24
Factors impacting hospitalisation and related health service costs in cancer survivors in Australia: Results from a population data linkage study in Queensland (COS‐Q)
Published 2024-09-01“…Cancer Medicine…”
Get full text
Article -
25
The efficacy of neoadjuvant immunotherapy and lymphocyte subset predictors in locally advanced esophageal squamous cell carcinoma: A retrospective study
Published 2024-09-01“…Cancer Medicine…”
Get full text
Article -
26
Impact of positive CD4 cells on event‐free survival in follicular lymphoma patients
Published 2024-09-01“…Cancer Medicine…”
Get full text
Article -
27
Gut microbial subtypes and clinicopathological value for colorectal cancer
Published 2024-09-01“…Cancer Medicine…”
Get full text
Article -
28
The current and future cancer burden in the Gulf Cooperation Council (GCC) countries
Published 2024-09-01“…Cancer Medicine…”
Get full text
Article -
29
PIK3CA mutational status in tissue and plasma as a prognostic biomarker in HR+/HER2− breast cancer
Published 2024-09-01“…Cancer Medicine…”
Get full text
Article -
30
Activin levels correlate with lymphocytic infiltration in epithelial ovarian cancer
Published 2024-09-01“…Cancer Medicine…”
Get full text
Article -
31
Clinical efficacy and safety of first‐line nilotinib or imatinib therapy in patients with chronic myeloid leukemia—Nationwide real life data
Published 2024-09-01“…Cancer Medicine…”
Get full text
Article -
32
-
33
Prognostic value of tumor‐infiltrating lymphocytes and PD‐L1 expression in esophageal squamous cell carcinoma
Published 2024-09-01“…Cancer Medicine…”
Get full text
Article -
34
Clinical and molecular response to alpha1‐oleate treatment in patients with bladder cancer
Published 2024-09-01“…Cancer Medicine…”
Get full text
Article -
35
Clinical relevance and druggability of sole reciprocal kinase fusions: A large‐scale study
Published 2024-09-01“…Cancer Medicine…”
Get full text
Article -
36
New clinical insights into the treatment of benign uretero‐ileal anastomotic stricture following radical cystectomy and urinary diversion
Published 2024-09-01“…Cancer Medicine…”
Get full text
Article -
37
Phase Ib/II study on the safety, tolerability, and preliminary efficacy of pegylated irinotecan (JK1201I) as second‐line monotherapy for patients with small‐cell lung cancer
Published 2024-09-01“…Cancer Medicine…”
Get full text
Article -
38
Expression of MxA in esophageal cancer cell lines can influence sensitivity to chemotherapeutic agents but this does not require apoptosis
Published 2024-09-01“…Cancer Medicine…”
Get full text
Article -
39
The interplay between persistent pathogen infections with tumor microenvironment and immunotherapy in cancer
Published 2024-09-01“…Cancer Medicine…”
Get full text
Article -
40
Preclinical evaluation of avutometinib and defactinib in high‐grade endometrioid endometrial cancer
Published 2024-09-01“…Cancer Medicine…”
Get full text
Article